Tasso
Facts
- HQ
- Seattle, Washington, US
- Sectors
- Medical Equipment Manufacturing
- Founded
- 2014
- Type
- Corporation Seattle business license
- Employees
- 99
- Registered name
- Tasso Inc Seattle business license
- Stage
- Seed
- Total raised
- $17M SEC Form D filings Total of this company's SEC Form D filings
- Last round
- $17M · Dec 2019 SEC Form D
- Founders
- Ben Casavant, PhD, Erwin Berthier, PhD
Seattle Startup Row Zero Raises $10 Million Seed Round to Revolutionize Big Data Spreadsheet Analysis
Seattle startup Row Zero raised $10 million in a seed round led by IA Ventures to develop a spreadsheet software optimized for big data analysis. Founded by former AWS engineers, the company aims to provide a faster, enterprise-grade alternative to traditional spreadsheets, with over 1,500 companies already using its platform.
Rippl Care Hires Jamie Sharp as Chief Medical Officer to Lead Senior Mental Health Program; Other Seattle Tech Startups Announce Key Executive Appointments
Seattle startup Rippl Care appointed Jamie Sharp, former Aetna VP and chief medical officer, as its new chief medical officer to advance its mental health care program for seniors. Additionally, Diego Oppenheimer joined Guardrails AI as co-founder, PitchBook hired Paul Stoddart as CMO, and Tasso appointed Monica Williams as CFO.
GeekWire returns in person for 2022 Awards at Showbox SoDo, honoring 60+ finalists across 15 categories with 16,000+ votes
GeekWire held its first in-person GeekWire Awards in three years at Showbox SoDo in Seattle, honoring 60+ finalists across 15 categories with over 16,000 community votes and appearances by local tech leaders and entertainers.
Five Finalists for 2022 GeekWire Health Innovation of the Year Include A-Alpha Bio and UW Institute for Protein Design
The 2022 GeekWire Health Innovation of the Year finalists include A-Alpha Bio, Parse Biosciences, Tasso, Truveta, and the University of Washington’s Institute for Protein Design, highlighting advances in computational health approaches. Winners will be announced on May 12 at the GeekWire Awards, with community voting open until April 22.
GeekWire revises GeekWire 200: firms >15 years old and majority PE-owned ineligible, rankings shift to quarterly in 2022
GeekWire is changing the criteria for its GeekWire 200 startup rankings: beginning in 2022, majority private-equity-owned companies and companies 15 years or older will be ineligible, and the index will move from monthly to quarterly updates, which will reshape the top ranks including removing Blue Origin.
Seattle’s Tasso Raises $100M Series B to Scale Self‑Administered Blood‑Collection Devices
Seattle startup Tasso raised $100 million in a Series B round to advance its self‑administered blood‑collection devices used for remote patient monitoring, decentralized clinical trials and mailed liquid or dried samples. The funding brings total capital to $131 million, building on prior grants and a $17 million raise in July 2020.
Study Finds Seattle Startup Tasso’s Tasso‑SST Self‑Collection Device Matches Venous COVID‑19 Antibody Results
A study led by Seattle researchers found the Tasso-SST self-administered upper-arm blood collection device produced antibody results nearly identical to venous draws and worked for a high proportion of users, even after simulated 48-hour shipping. The device, made by Seattle startup Tasso, could replace some clinic blood draws for COVID-19 antibody testing.
GeekWire 200 update: Remitly No. 3 as proposed IPO looms; Hootsuite debuts No. 6, Convoy rises to No. 7
GeekWire updated its GeekWire 200 list highlighting Pacific Northwest private tech startups amid record investment and M&A activity, with trends toward virtual experiences, at-home healthcare, remote education, and e-commerce. Notable rankings: Remitly at No. 3 (last valued $1.5B, proposed IPO), Hootsuite debuted at No. 6, Convoy rose to No. 7 (valued $2.75B in 2019), and Fabric jumped 26 spots to No. 95.
Tasso raises $17M to expand Tasso OnDemand at-home blood collection platform; CEO cites pandemic-driven demand
Seattle startup Tasso raised $17 million to expand its Tasso OnDemand at-home blood collection platform, which lets users self-collect and mail samples for lab testing; CEO Ben Casavant says the COVID-19 pandemic has increased demand for patient-friendly, at-home diagnostics.
